CHARACTERIZATION OF WOMEN WITH INFLAMMATORY BOWEL DISEASE AND EXPOSURE TO BIOLOGICS OR IMMUNOMODULATORS DURING PREGNANCY

被引：0
|
作者：
Wang, Sarah
Pena-Sanchez, Juan-Nicolas
Winquist, Brandace
Li, Wenbin
Jones, Jennifer L.
Fowler, Sharyle A.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1799
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease
    Saha, Sumona
    Wald, Arnold
    [J]. EXPERT OPINION ON DRUG SAFETY, 2012, 11 (06) : 947 - 957
  • [2] Safety of Immunomodulators and Biologics for the Treatment of Inflammatory Bowel Disease During Pregnancy and Breast-feeding
    Gisbert, Javier P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (05) : 881 - 895
  • [3] VACCINATION OF INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNOMODULATORS AND BIOLOGICS
    Tan, J.
    Yap, K.
    Hong, L.
    Babu, P.
    [J]. GUT, 2015, 64 : A233 - A233
  • [4] Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
    Clarke, Kofi
    Regueiro, Miguel
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 174 - 179
  • [5] Vaccination Strategies for Patients with Inflammatory Bowel Disease on Immunomodulators and Biologics
    Melmed, Gil Y.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1410 - 1416
  • [6] Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
    Mahadevan, Uma
    Long, Millie D.
    Kane, Sunanda, V
    Roy, Abhik
    Dubinsky, Marla C.
    Sands, Bruce E.
    Cohen, Russell D.
    Chambers, Christina D.
    Sandborn, William J.
    [J]. GASTROENTEROLOGY, 2021, 160 (04) : 1131 - 1139
  • [7] Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy
    Volger, S. H. E. R., I
    Scherl, E. L. L. E. N.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : 962 - 963
  • [8] Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease
    Kreijne, J. E.
    Goetgebuer, R. L.
    Erler, N. S.
    De Boer, N. K.
    Siebers, A. G.
    Dijkstra, G.
    van Kemenade, F. A.
    Hoentjen, F.
    Oldenburg, B.
    van der Meulen, A. E.
    Ponsioen, C. I. J.
    Pierik, M. J.
    van der Woude, C. J.
    de Vries, A. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (02) : 207 - 217
  • [9] Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    [J]. DIGESTION, 2023, 104 (01) : 66 - 73
  • [10] Association of Thyroid Cancer with The Use of Biologics and Immunomodulators in Inflammatory Bowel Disease Patients
    Fialho, Andrea
    Fialho, Andre
    Kochhar, Gursimran
    Shen, Bo
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 : S33 - S34
12345